Analyst Upgrades

• Molycorp (MCP) to overweight from neutral at JPMorgan.
• Humana (HUM), HealthSpring (HS) and UnitedHealth (UNH) to buy from neutral at UBS.
• Williams Cos. (WMB) to conviction buy from neutral and UBS (UBS) to buy from neutral at Goldman.
• China Kanghui (KH) to overweight from neutral at Piper Jaffray.
• Arthur J. Gallagher (AJG) to buy from hold at Citigroup.
• Armstrong World (AWI) to buy from hold at BB&T.
• Time Warner (TWX) to buy from hold at Benchmark Co.
• Calpine (CPN) to overweight from equal weight at Barclays.
• 3M Company (MMM) to neutral from underperform and Kirby (KEX) to buy from underperform at BofA/Merrill.

Analyst Upgrades

• Goldman upgraded Eaton (ETN) to conviction buy from neutral.
• AECOM Technology (ACM) was upgraded to outperform from neutral at Macquarie.
• Piper Jaffray upgraded Hologic (HOLX), Gen-Probe (GPRO) and Qiagen (QGEN) to overweight from neutral.
• GeoMet (GMET) was upgraded to accumulate from neutral at Global Hunter.
• Accretive Health (AH) was upgraded to outperform from neutral at RW Baird.
• Morgan Stanley upgraded Reinsurance Group (RGA) to overweight from equal weight.
• BofA/Merrill upgraded Clearwire (CLWR) to neutral from underperform.

Analyst Upgrades

• Deutsche Bank upgraded EMC (EMC) to buy from hold after channel checks indicated storage demand remains solid. The firm sees potential upside in 2011 from the company's new products and upped its target for shares to $25 from $20.
• BB&T upgraded American Commercial (ACLI) to buy with a $50 target based on pricing leverage and cost reductions.
• Argus upgraded Abercrombie (ANF) to buy with a $52 target based on accelerating comps.
• PerkinElmer (PKI) was upgraded to equal weight from underweight at Barclays.
• Valeant (VRX) was upgraded to market perform from underperform at Wells Fargo with a $26 to $28 valuation range.
• Blackrock (BLK) was upgraded to buy from hold at Deutsche Bank.

Hopefully all the people who thought the world was coming to an end have found good counseling while the rest of us get on with our business. This is not to make light of those that are struggling to find employment, or trying to rebuild their retirement portfolios -- this is a brutal economy indeed.

The most important thing, though, is that the stock market has improved recently, "bear rally" or not, because it has allowed investors to see that the market can go up as well as down. The most reliable prediction for the future of the stock market has always been "it will fluctuate".

My favorite motto comes from my time as a Cub Scout: be prepared. If you do not have a watchlist then you are not prepared. Yesterday I started this conversation with Serious Money: Keep your eyes on UPS and FDX.

Analyst upgrades:

• Citigroup upgraded Tyco (NYSE: TYC) shares to Buy from Hold on valuation as they believe the recent weakness has created an attractive entry point. The firm lowered its target price to $25 from $26.
  
• Deutsche Bank raised SAP (NYSE: SAP) to Buy from Hold on valuation as it finds the risk/reward attractive at current levels.
  
• Oppenheimer upgraded Onlin Corp (NYSE: OLN) to Outperform from Perform on valuation as it sees strong support at $10 and potential upside to $20. The firm has a $20 target on the stock.
• JP Morgan (NYSE: JPM) and Blackstone (NYSE: BX) were upgraded to Outperform from Market Perform at Keefe Bruyette.
  
• Adobe (NASDAQ: ADBE) was raised to Neutral from Sell at UBS.
  
• Goldman added AT&T (NYSE: T) to the Conviction Buy List.

MOST NOTEWORTHY: Sigma Designs, Satyam and Genpact were today's noteworthy initiations:

• Deutsche Bank initiated shares of Sigma Designs (NASDAQ: SIGM) with a Buy rating and $62 target, as they believe the company can maintain its leadership position in the fast-growing IPTV and high-def DVD markets. Baird said Sigma's IPTV momentum is accelerating, Blu-ray demand in strong, and Ultrawideband is the next growth opportunity. The firm resumed coverage with an Outperform rating.
  
• Banc of America started shares of Satyam Computer Services (NYSE: SAY) with a Neutral rating and $39 target on valuation, as they believe better value exists in peers Cognizant Technology (NASDAQ: CTSH) and Infosys Technologies (NASDAQ: INFY).
  
• UBS initiated Genpact (NYSE: G) with a Neutral rating and $18 target on valuation.

OTHER INITIATIONS:

• Goldman resumed coverage of HealthSpring (NYSE: HS) with a Neutral rating and $23 target.
  
• Wachovia initiated Gentiva Health (NASDAQ: GTIV) with an Outperform rating.

MOST NOTEWORTHY: HealthSpring (HS), CoPart (CPRT), Multi Fineline Electronix (MFLX) and Global Traffic Network (GNET) were today's noteworthy initiations:

• HealthSpring (NYSE: HS) was initiated with a Neutral rating and $20 target at Banc of America, as the firm doesn't expect earnings growth to recover until 2009.

• Rochdale Research started CoPark (NASDAQ: CPRT) with a Buy and $36 target yesterday. The firm said CoPark is in an excellent competitive position and expects growth to re-accelerate as the company integrates and expands its non-U.S. platform.

• Needham reinstated shares of Multi Fineline Electronix (NASDAQ: MFLX) with a Buy rating and $13 target, as the firm believes the current valuation overly discounts the company's opportunities with Sony-Ericsson (SNE/ERIC), Apple (AAPL), and the likelihood of stability at Motorola (MOT).

• Oppenheimer initiated shares of Global Traffic Network (NASDAQ: GNET) with a Buy rating and $9.50 target as the firm believes the company's expansion into new territories such as Canada and the UK should enable double-digit revenue and cash flow growth for the long term.

OTHER INITIATIONS:

• Goldman Sachs reinstated shares of Qiagen (NASDAQ: QGEN) with a Neutral rating.

• Raymond James initiated shares of Research in Motion (NASDAQ: RIMM) with an Outperform rating and $275 target.

• NexCen Brands (NASDAQ: NEXC) was started at Lazard with a Buy rating.

• BMO Capital initiated shares of INVESTools (NASDAQ: SWIM) with an Outperform rating.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

MOST NOTEWORTHY: PetSmart, Inc (PETM), Google (GOOG), Dr. Reddy's Laboratories Ltd (RDY) and Optimal Group Inc (OPMR) were today's more noteworthy downgrades:

• Stifel cut PetSmart Inc (NASDAQ: PETM) to Hold from Buy biting valuation.

• First Global downgraded shares of Google Inc (NASDAQ: GOOG) to Market Perform from Outperform.

• Morgan Stanley downgraded shares of Dr. Reddy's Laboratories (NYSE: RDY) to Equal-Weight from Overweight after a U.S. court ruling appeared set to block generic competition to Japanese company Eisai Co, Ltd's (ESALY) ulcer drug Aciphex.

• B. Riley downgraded shares of Optimal Group (NASDAQ: OPMR) to Neutral from Buy to reflect increasing uncertainty regarding further legal actions, which may be taken by the U.S. Attorney's office against the company...

OTHER DOWNGRADES:

• Friedman Billings downgraded Allied Defense Group (NYSE: ADG) to Market Perform from Outperform.

• Sandler cut Boston Private Financial Holdings Inc (NASDAQ: BPFH) to Hold from Buy.

• Raymond James downgraded both HealthSpring, Inc (NYSE: HS) and Emageon, Inc (NASDAQ: EMAG) to Market Perform from Outperform.

• Teck Cominco Ltd (NYSE: TCK) was downgraded to Sector Performer from Sector Outperformer at CIBC.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).